A leading pharmaceutical company required a flawless global distribution network for a highly sensitive vaccine requiring strict temperature control between 2°C and 8°C. Any temperature excursion beyond this narrow band would render the cargo completely useless, resulting in millions of dollars in losses and severe public health implications. Traditional air freight handovers posed an unacceptable risk of temperature deviations.
We architected an active cold-chain lane using temperature-controlled ULDs where appropriate, with IoT loggers streaming temperature, humidity, and location data to a 24/7 control tower. Where regulators and carriers support it, we align pre-clearance steps so hand-offs avoid unnecessary apron dwell.
In this illustrative cold-chain programme, the operating model emphasised active ULDs, continuous telemetry, and control-tower oversight so that temperature excursions could be detected and corrected early. Outcomes such as dose counts, lane counts, or excursion rates always depend on lane design, airline partners, and regulatory context for each shipment.
